SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jenna who wrote (48455)7/4/1999 2:04:00 PM
From: SMALL FRY  Read Replies (1) of 120523
 
Jenna,

Hot diggity. As Burjis always say: "Brilliant people always think alike... fools seldom differ."

As part of my IT holding renovation/diversification, I bought into IMNX, IMCL and this little company VICL... I figured it's time for biotechs to make a few moves with the publicities they've been accorded recently. IMCL and IMNX we all know... VICL (Vical Inc) begun their Allovectin-7 (metastatic melanoma cure) Phase III trials in mid-1998 and target launch date is early 2000.

VICL - worth a DD I believe... I have a small position and intend to add if the biotech/gene therapy sector heats up.

Regards,
SF
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News